Mana.bio: Funding, Investors & Team (Sep 2026)
Mana.bio is a startup that utilizes artificial intelligence for delivering medications, specifically targeting gene therapy such as DNA and RNA-based treatments, as well as vaccines.
Mana.bio has raised $24.5M across 3 funding rounds on record, the most recent a Seed announced in Sep 2025.
Mana.bio Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Mana.bio Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Mana.bio raised $5.0M in a Seed announced in Oct 2022.
1 years later, a Seed of $19.5M was announced in Oct 2023.
1.9 years later, a Seed was announced in Sep 2025 with no disclosed amount.
Mana.bio Founders and Leadership Team
Contact details for the Mana.bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Mana.bio Funding Compared to Other Biotechnology Startups
Funded Startups Like Mana.bio in Biotechnology and San Francisco
Companies Similar to Mana.bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Mana.bio Funding FAQs
What does Mana.bio do?
Mana.bio is a startup that utilizes artificial intelligence for delivering medications, specifically targeting gene therapy such as DNA and RNA-based treatments, as well as vaccines.
How much funding has Mana.bio raised?
Mana.bio has raised $24.5M across 3 rounds on record.
When did Mana.bio last raise funding?
Mana.bio's most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who founded Mana.bio?
FundedIQ lists Roy Nevo (Founder) at Mana.bio.
Who is the CEO of Mana.bio?
Yogev Debbi is listed as CEO at Mana.bio.
Where is Mana.bio headquartered?
Mana.bio is based in San Francisco, California, United States.
How many employees does Mana.bio have?
Mana.bio is in the 11-50 employee band.
About FundedIQ's Mana.bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mana.bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.